Dissecting individual pathogen-commensal interactions within a complex gut microbiota community
Preprint posted on 6 April 2020 https://www.biorxiv.org/content/10.1101/2020.04.06.027128v1
Examination of how commensal bacteria interact with the pathogen C. difficile to prevent pathogenic infection within a biofilmSelected by Josie Gibson
The microbiota of the gut has multiple important roles, including metabolism, immune function and inhibition of pathogen colonisation. Commensals inhibit pathogen colonisation through resource competition, and directly through production of targeted antimicrobial molecules. In cases where alterations to the microbiota occur, for example following antibiotic treatment, disease can arise. This can lead to a higher risk of infection by pathogenic bacteria, for example Clostridioides difficile. This pre-print presents a new qPCR analysis of an in vitro multi-species gut community which is then used to examine how the microbiota interacts with C. difficile within this biofilm situation. This technique allows the authors to specifically examine individual bacterial interactions which is not possible in genomic approaches.
qPCR biofilm analysis
The authors first validate their qPCR biofilm analysis by comparing individual commensal bacterial growth within a biofilm, where all bacterial species are individually detected. This method also excludes dead bacterial cells allowing accurate examination of live bacteria. Currently the method cannot be used for long periods of time since bacterial survival begins to decline. Nevertheless, a useful experimental window of up to 72 hours is available and the method is employed to examine how microbiota interact with C. difficile.
Gut microbiota impede C. difficile colonisation
The ability of C. difficile to adhere and grow was reduced in the presence of the microbiota at the first stages of biofilm formation, whereas commensal bacterial species adherence was increased and their growth was similar or increased, compared to culture without C. difficile. This highlights how the microbiota can influence pathogenic species. The inhibitory effects upon C. difficile were enhanced when added to an existing biofilm, which better represents an established gut microbiota. Interestingly, individual commensals reacted differently when C. difficile was added to an existing biofilm, resulting in either a reduced, similar or increased bacterial number. A large increase in commensal growth was observed for Bacteroides dorei. Further experiments focussing on B. dorei alone, revealed that B. dorei bacterial numbers were increased in the presence of C. difficile, whilst also causing reduced C. difficile bacterial numbers. Therefore, this microbiota analysis enabled identification of key individual bacterial interactions within a complex microbial biofilm setting. Furthermore, pre-established microbiota was shown to be better at protecting against C. difficile, compared to addition of C. difficile at the stage of biofilm formation, signifying that alterations in the microbiota represent a foothold for C. difficile infection. Therefore, this methodology reflects real-life C. difficile infections, where infection likelihood is increased following changes in the microbiota, such as those caused by antibiotic treatment.
Why I chose this Preprint:
This pre-print is of interest for the study of host-pathogen interactions, especially how commensal bacteria regulate pathogenic infections. A new in vitro methodology for analysis of pathogen and commensal interactions within a microbial biofilm setting, more akin to the natural infection scenarios, is defined. The method described by the authors compares growth of individual bacterial species in co-culture conditions, which provides useful insights into infection dynamics and pathogen-commensal interactions. This pre-print demonstrates how this method can be applied, showing that C. difficile adherence in the biofilm setting is reduced in the presence of other commensal bacteria. The authors could then identify that out of nine commensal bacterial species used, Bacteroides dorei has a key role in reducing C. difficile growth.
Questions to the authors:
- In your assay, the trend of dying over time for bacterial species is shown. Therefore, could the biofilms be given fresh media/extra supplements to increase the timeframe of analysis? Do think improved fitness of all bacterial species would alter commensal-pathogen interactions?
- In the gut would the nine chosen commensal bacteria all be in equal number to start with? If not, could the numbers of bacteria present at the establishment of the biofilm be important for future analysis?
- You show that dorei negatively impacts C. difficile, and suggest these may be due to metabolic or soluble factors. Are there bacterial mutants available for these potential factors you could examine?
- C. difficile infection often occurs after alterations in the gut microbiome. If it is possible to determine the factor by which B. dorei negatively impacts C. difficile, do you envisage any therapeutic outcomes to influence C. difficile, during or after antibiotic treatment?
Posted on: 5 May 2020 , updated on: 25 March 2021
doi: https://doi.org/10.1242/prelights.20064Read preprint
Also in the microbiology category:
Humoral and T-cell-mediated responses to a pre-clinical Zika vaccine candidate that utilizes a unique insect-specific flavivirus platform
Transcriptional units form the elementary constraining building blocks of the bacterial chromosome
The cell envelope of Thermotogae suggests a mechanism for outer membrane biogenesis
preListsmicrobiology category:in the
BioMalPar XVI: Biology and Pathology of the Malaria Parasite
[under construction] Preprints presented at the (fully virtual) EMBL BioMalPar XVI, 17-18 May 2020 #emblmalaria
|List by||Dey Lab, Samantha Seah|
ECFG15 – Fungal biology
Preprints presented at 15th European Conference on Fungal Genetics 17-20 February 2020 Rome
|List by||Hiral Shah|
EMBL Seeing is Believing – Imaging the Molecular Processes of Life
Preprints discussed at the 2019 edition of Seeing is Believing, at EMBL Heidelberg from the 9th-12th October 2019
|List by||Dey Lab|
Antimicrobials: Discovery, clinical use, and development of resistance
Preprints that describe the discovery of new antimicrobials and any improvements made regarding their clinical use. Includes preprints that detail the factors affecting antimicrobial selection and the development of antimicrobial resistance.
|List by||Zhang-He Goh|